John Lynch, CPA, is a seasoned finance professional with extensive experience in financial planning, analysis, and accounting across prominent organizations in the pharmaceutical and healthcare sectors. Currently serving as Senior Director of Financial Planning and Analysis at Incyte since March 2021, John previously held roles such as Sr. Director of Finance & Accounting at Nabriva Therapeutics plc and various finance management positions at AstraZeneca, Pfizer, and Rohm & Haas. John’s expertise includes market access finance, business forecasting, and financial reporting, with a proven track record of supporting strategic planning and achieving financial performance objectives. John holds a Bachelor of Science in Accounting from Widener University.
This person is not in any teams
This person is not in any offices